Display options
Cite
Barysheva EV, Selivanov SP, Riannel JE, et al. Relationship of uptake of 99mTc-MIBI in bone metastases to efficiency of strontium-89 therapy in prostate cancer patients. Nucl Med Rev Cent East Eur. 1999;2(2):63-8
Barysheva, E. V., Selivanov, S. P., Riannel, J. E., Isaeva, S. N., Usynin, E. A., Velichko, S. A., & Ussov, W. Y. (1999). Relationship of uptake of 99mTc-MIBI in bone metastases to efficiency of strontium-89 therapy in prostate cancer patients. Nuclear medicine review. Central & Eastern Europe, 2(2), 63-8.
Barysheva, E V, et al. "Relationship of uptake of 99mTc-MIBI in bone metastases to efficiency of strontium-89 therapy in prostate cancer patients." Nuclear medicine review. Central & Eastern Europe vol. 2,2 (1999): 63-8.
Barysheva EV, Selivanov SP, Riannel JE, Isaeva SN, Usynin EA, Velichko SA, Ussov WY. Relationship of uptake of 99mTc-MIBI in bone metastases to efficiency of strontium-89 therapy in prostate cancer patients. Nucl Med Rev Cent East Eur. 1999;2(2):63-8. PMID: 14600917.
Copy Download .nbib Format: NLM
Share it on

Nucl Med Rev Cent East Eur. 1999;2(2):63-8.

Relationship of uptake of 99mTc-MIBI in bone metastases to efficiency of strontium-89 therapy in prostate cancer patients.

Nuclear medicine review. Central & Eastern Europe

E V Barysheva, S P Selivanov, J E Riannel, S N Isaeva, E A Usynin, S A Velichko, W Y Ussov

Affiliations

  1. Institutes of Oncology and Cardiology, Tomsk Medical Research Centre, Siberia, Russia.

PMID: 14600917

[No abstract available.]

Publication Types